Gianna Hoffman-Luca is a seasoned professional in the pharmaceutical and venture capital sectors, currently serving as a Partner at Xontogeny and as Senior Principal for PXV Funds at Perceptive Advisors. With extensive board experience at Avalyn Pharma Inc. and Adaptilens, along with a board observer role at Avenge Bio, Gianna demonstrates a strong commitment to advancing innovative healthcare solutions. Gianna holds a Doctor of Philosophy (PhD) in Pharmacology from the University of Michigan Medical School and a Master of Science (M.Sc.) in Chemistry from the University of California, Santa Cruz.